v3.26.3
SCHEDULE OF BASIC AND DILUTED EARNINGS PER SHARE (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Earnings Per Share [Abstract]        
Net loss from continuing operations $ (4,469,713) $ (4,574,977) $ (20,585,088) $ (10,007,701)
Less: Preferred stock dividends (776,563) (776,563) (2,329,688) (2,329,688)
Net loss from continuing operations attributable to LifeMD, Inc. common stockholders (5,246,276) (5,351,540) (22,914,776) (12,337,389)
Net income from discontinued operations 935,013 4,821,519
Less: Net income attributable to noncontrolling interests of discontinued operations 249,462 1,286,382
Net income from discontinued operations attributable to LifeMD, Inc. 685,551 3,535,137
Net loss attributable to LifeMD, Inc. common stockholders $ (5,246,276) $ (4,665,989) $ (22,914,776) $ (8,802,252)